Alexander Helmer

Alexander Helmer

Auto-generated profile, based on publicly available information

Alexander Helmer

Department of Otorhinolaryngology—Head and Neck Surgery, University Hospital Mannheim, Medical Faculty of the Ruprecht-Karls-University of Heidelberg, Baden-Wüttemberg, Germany

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2025 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
AHAlexander Helmer
Alexander Helmer
MCMarcio Cantillo
Marcio Cantillo
LZLena Zaubitzer
Lena Zaubitzer
BKBenedikt Kramer
Benedikt Kramer
NRNicole Rottery
Nicole Rottery
DHDaniel Häussler
Daniel Häussler
Introduction: Auricular keloids may be associated with social stigma and impair patients’ quality of life (QoL) significantly. Little is known about the effect of different therapeutic concepts on the patient’s QoL. This study aims to investigate the QoL in patients with auricular keloids undergoing a specific multimodal therapeutic regimen. Materials and Methods: Patients suffering from auricular keloids were treated by a multimodal treatment comprising surgical excision, intralesional triamcinolone acetonide, and subsequent application of customized magnetic pressure splints. A prospective assessment of QoL was conducted using the validated Keloid Intervention Benefit Inventory-21 questionnaire at three time points. Results: In total, 22 auricular keloids were included in our study. All patients completed a comprehensive 1-year follow-up assessment, with an average follow-up duration of 29 months post-surgery. Quantitative analysis of QoL metrics demonstrated significant improvement of QoL at the three times of measurement ( P < .0001). Significant results were also found for the subcategories general health, physical health, social interaction, and self-esteem. Conclusion: This study underscores the necessity of assessment of QoL in keloid treatment. Our findings highlight the advantages of multimodal treatment in enhancing patients’ QoL throughout the treatment period and managing auricular keloids with low recurrence. Trial Registration: The study was registered at the German Clinical Trials Register (Register ID: DRKS00016348, https://drks.de/search/en/trial/DRKS00016348 ).